Kynam Capital Management, LP Sutro Biopharma, Inc. Call Options Transaction History
Kynam Capital Management, LP
- $837 Million
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding STRO
# of Institutions
106Shares Held
59.2MCall Options Held
92.8KPut Options Held
0-
Black Rock Inc. New York, NY6.91MShares$6.36 Million0.0% of portfolio
-
Suvretta Capital Management, LLC New York, NY6.49MShares$5.97 Million0.16% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.73MShares$4.35 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.12MShares$3.79 Million0.0% of portfolio
-
Velan Capital Investment Management LP Alpharetta, GA3.06MShares$2.82 Million3.73% of portfolio
About SUTRO BIOPHARMA, INC.
- Ticker STRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,161,500
- Market Cap $48M
- Description
- Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...